Warfarin Use and Risk for Osteoporosis in Elderly Women

  1. Sophie A. Jamal, MD;
  2. Warren S. Browner, MD, MPH;
  3. Douglas C. Bauer, MD; and
  4. Steven R. Cummings, MD
  1. For the Study of Osteoporotic Fractures Research Group* From University of California, San Francisco, and San Francisco Veterans Affairs Medical Center, San Francisco, California. *For members of the Study of Osteoporotic Fractures Research Group, see Ann Intern Med. 1996; 124:187-96. Acknowledgments: The authors thank Dr. Ahmed Bayoumi for helpful comments on earlier versions of this paper. Grant Support: By grants AG05407, AR35582, AG05394, AM35584, AR35583, and NS36016 from the National Institutes of Health, Public Health Service. Requests for Reprints: Sophie A. Jamal, MD, Prevention Sciences Group, Suite 512, 74 New Montgomery Street, San Francisco, CA 94105; e-mail sophie_jamal@quickmail.ucsf.edu. Current Author Addresses: Dr. Jamal: Suite 512, 74 New Montgomery Street, San Francisco, CA 94105.

    Abstract

    Background: Vitamin K deficiency may be associated with osteoporosis.

    Objective: To assess the effects of warfarin on bone.

    Design: Prospective observational study.

    Setting: Four centers in the United States.

    Participants: 6201 elderly, postmenopausal women.

    Measurements: Self-reported warfarin use, bone mineral density at the hip and the heel, hip bone loss over 2 years, and fractures during 3.5 years of follow-up. Analyses were adjusted for baseline differences, age, weight, and estrogen use.

    Results: Compared with warfarin nonusers (n = 6052), warfarin users (n = 149) more frequently had poor health, involuntary weight loss, nonthiazide diuretic use, and frailty but had similar bone mineral density at the hip (difference, 1.6% [95% CI, −0.7% to 4.1%]) and heel (difference, 2.1% [CI, −1.6% to 5.6%]). Users and nonusers had similar rates of bone loss (1.1% and 0.8%; P = 0.18) and fractures (relative hazard, 1.0 [CI, 0.60 to 1.7]).

    Conclusion: In this population, warfarin use did not decrease bone mineral density or increase fracture rates.

    | Table of Contents
    Most Read Most Read
    Most Commented Most Commented On
    Annals in the News Annals in the News
    Clinical Trials Clinical Trials
    Comparative Effectiveness Comparative Effectiveness
    Hospital Medicine Hospital Medicine
    • Advertisement
    • Advertisement